John J. Sperzel III - Feb 20, 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chairman, President and Chief Executive Officer, Director
Signature
/s/ John Sprague, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Feb 20, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 05:29 PM
Next filing
Feb 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Award $0 +2.4M $0.00 2.4M Feb 20, 2022 Common Stock 2.4M Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The restricted stock units vest in three equal annual installments commencing on February 20, 2023.

Remarks:

Chairman, President and Chief Executive Officer